Ocular Therapeutix (OCUL) Other Non Operating Income (2013 - 2026)

Ocular Therapeutix (OCUL) recorded quarterly Other Non Operating Income of $1.8 million in Q1 2026, up 4.99% quarter-over-quarter from $1.7 million in Q4 2025, and up 402.31% on a YoY basis from $364714.8 in Q1 2025.

Ocular Therapeutix (OCUL) Other Non Operating Income (2013 - 2026) Analysis & Trends

Ocular Therapeutix's Other Non Operating Income history runs 13 years deep, the most recent figure standing at $1.8 million for Q1 2026.

  • In Q1 2026, Other Non Operating Income rose 402.31% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $2.5 million (down 45.82% YoY), while the FY2025 annual figure was $29000.0, up 100.1% from the prior year.
  • Other Non Operating Income was $1.8 million for Q1 2026 at Ocular Therapeutix, up from $1.7 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $14.2 million in Q3 2023 to a low of -$28.0 million in Q1 2024.
  • Historically, Other Non Operating Income has averaged -$1.1 million across 5 years, with a median of -$1000.0 in 2023.
  • The sharpest annual moves came in 2023 and 2024: Other Non Operating Income surged 1418900.0% in 2023, then tumbled 2794900.0% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at $1000.0 in 2022, then tumbled by 1419200.0% to -$14.2 million in 2023, then soared by 153.65% to $7.6 million in 2024, then sank by 77.08% to $1.7 million in 2025, then gained by 4.99% to $1.8 million in 2026.
  • The last three Other Non Operating Income figures came in at $1.8 million (Q1 2026), $1.7 million (Q4 2025), and -$938000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Ocular Therapeutix 2.12 Bn 2.12 Bn 9.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.83 Mn
Dec 31, 2025 1.75 Mn
Sep 30, 2025 -938,000.00
Jun 30, 2025 -172,000.00
Mar 31, 2025 -606,000.00
Sep 30, 2024 7.61 Mn
Jun 30, 2024 -2.45 Mn
Mar 31, 2024 -27.95 Mn
Dec 31, 2023 -14.19 Mn
Sep 30, 2023 14.19 Mn
Jun 30, 2023 1.13 Mn
Mar 31, 2023 -1,000.00
Sep 30, 2022 1,000.00
Jun 30, 2022 2.77 Mn
Mar 31, 2022 -2,000.00
Dec 31, 2021 -62.25 Mn
Sep 30, 2021 23.84 Mn
Jun 30, 2021 13.40 Mn
Mar 31, 2021 25.02 Mn
Dec 31, 2020 -69.55 Mn